Corona virus vaccine: Corona virus vaccine is partnered with UK firm Oxford to assess T cell response World News

Corona virus vaccine: Corona virus vaccine is partnered with UK firm Oxford to assess T cell response World News

LONDON: The UK said on Thursday it would partner with an Oxford-based company to test the T-cell response of candidates for the corona virus vaccine to gauge their immune response.
Cell T cell immunity is thought to be necessary to protect against infection with the SARS-COV2 corona virus, and it may provide long-term immunity to antibodies.
The UK Vaccine Task Force has selected Oxford Immunotech to provide T-cell testing to test a variety of vaccine candidates.
Kate Bingham, Chair of the UK Vaccine Task Force, said: “It is important that we review the different head-to-head vaccines and that the T-cell response is part of our approved base portfolio that we use for cross-comparison. Are doing. ” In a statement
The UK has signed supply deals for six different corona virus vaccine candidates, including AstraZeneca and Pfizer and Biotech are among the leaders in the vaccination race.
Oxford Immunotech said its technology platform has centralized fresh blood samples from various locations to measure T cell response in a standardized manner.
He said the platform, known as T-SPOT, was being used to identify T cells created in response to the pathogen that causes tuberculosis.

STAY TUNED WITH US FOR MORE INTERESTING CONTENT ONLY ON DESINEW.XYZ

Leave a Reply

Your email address will not be published. Required fields are marked *